BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17600596)

  • 1. A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Zwerdling A; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 Aug; 25(32):5958-67. PubMed ID: 17600596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.
    Cassataro J; Velikovsky CA; Bruno L; Estein SM; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Clin Vaccine Immunol; 2007 Jul; 14(7):869-74. PubMed ID: 17428946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.
    Estein SM; Fiorentino MA; Paolicchi FA; Clausse M; Manazza J; Cassataro J; Giambartolomei GH; Coria LM; Zylberman V; Fossati CA; Kjeken R; Goldbaum FA
    Vaccine; 2009 Nov; 27(48):6704-11. PubMed ID: 19748579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
    Cassataro J; Velikovsky CA; de la Barrera S; Estein SM; Bruno L; Bowden R; Pasquevich KA; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Oct; 73(10):6537-46. PubMed ID: 16177328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM; Estevan M; Marín CM; Jesús De Miguel M; Jesús Grilló M; Barberán M; Irache JM; Blasco JM; Gamazo C
    Vaccine; 2006 Mar; 24(11):1897-905. PubMed ID: 16337315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ; Marín CM; Barberán M; de Miguel MJ; Laroucau K; Jacques I; Blasco JM
    Vaccine; 2009 Jan; 27(2):187-91. PubMed ID: 19007836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis.
    Estein SM; Cheves PC; Fiorentino MA; Cassataro J; Paolicchi FA; Bowden RA
    Vet Microbiol; 2004 Sep; 102(3-4):203-13. PubMed ID: 15327795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.
    Commander NJ; Spencer SA; Wren BW; MacMillan AP
    Vaccine; 2007 Jan; 25(1):43-54. PubMed ID: 17049676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A; Abbady AQ
    J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
    Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
    Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
    Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of immune response in mice with a DNA vaccine encoding outer membrane protein (omp31) of Brucella melitensis 16M.
    Gupta VK; Rout PK; Vihan VS
    Res Vet Sci; 2007 Jun; 82(3):305-13. PubMed ID: 17014873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
    Estein SM; Cassataro J; Vizcaíno N; Zygmunt MS; Cloeckaert A; Bowden RA
    Microbes Infect; 2003 Feb; 5(2):85-93. PubMed ID: 12650766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.